Search Results - "Abdel‐Wahab, Zeinab"

Refine Results
  1. 1

    Optimizing a Novel Regional Chemotherapeutic Agent against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity by SAE HEE KO, UENO, Tomio, TYLER, Douglas S, YOSHIMOTO, Yasunori, JIN SOO YOO, ABDEL-WAHAB, Omar I, ABDEL-WAHAB, Zeinab, CHU, Edward, PRUITT, Scott K, FRIEDMAN, Henry S, DEWHIRST, Mark W

    Published in Clinical cancer research (01-01-2006)
    “…Purpose: Previous preclinical studies have shown that regional temozolomide therapy via isolated limb infusion is more effective than melphalan, the current…”
    Get full text
    Journal Article
  2. 2

    Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer by Grubbs, Elizabeth G, Abdel-Wahab, Zeinab, Tyler, Douglas S, Pruitt, Scott K

    Published in Annals of surgical oncology (01-12-2006)
    “…Real-time quantitative polymerase chain reaction (qPCR) may prove to be a sensitive technique by which to evaluate potential tumor markers in pancreatic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice by De Matos, Pierre, Abdel-Wahab, Zeinab, Vervaert, Carol, Hester, Dina, Seigler, Hilliard

    Published in Journal of surgical oncology (01-06-1998)
    “…Background and Objectives: Dendritic cells (DC) pulsed in vitro with a variety of antigens have proved effective in producing specific antitumor effects in…”
    Get full text
    Journal Article
  5. 5

    MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases by Dong, Xiang Da, Abdel-Wahab, Zeinab, Dematos, Pierre, Fong, Timothy, Pruitt, Scott K., Seigler, Hilliard F.

    Published in Journal of surgical oncology (01-05-1999)
    “…Background and Objectives Vaccination with cytokine gene‐modified tumor cells augments the immune response against established tumors and protects against…”
    Get full text
    Journal Article
  6. 6

    Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4 by Cisco, Robin M, Abdel-Wahab, Zeinab, Dannull, Jens, Nair, Smita, Tyler, Douglas S, Gilboa, Eli, Vieweg, Johannes, Daaka, Yehia, Pruitt, Scott K

    Published in The Journal of immunology (1950) (01-06-2004)
    “…Maturation of dendritic cells (DC) is critical for the induction of Ag-specific immunity. Ag-loaded DC matured with LPS, which mediates its effects by binding…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Phase I clinical trial of immunotherapy with interferon-γ gene-modified autologous melanoma cells : Monitoring the humoral immune response by ABDEL-WAHAB, Z, WELTZ, C, HESTER, D, PICKETT, N, VERVAERT, C, BARBER, J. R, JOLLY, D, SEIGLER, H. F

    Published in Cancer (01-08-1997)
    “…Tumor cells transduced with cytokine genes provide immunogenic vaccines for cancer immunotherapy. A Phase I clinical trial was conducted for the specific…”
    Get full text
    Journal Article
  9. 9

    Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses by Abdel-Wahab, Zeinab, Cisco, Robin, Dannull, Jens, Ueno, Tomio, Abdel-Wahab, Omar, Kalady, Matthew F., Onaitis, Mark W., Tyler, Douglas S., Pruitt, Scott K.

    Published in The Journal of surgical research (01-04-2005)
    “…Cotransfection of dendritic cells (DC) with MART-1 and constitutively active TLR4 (caTLR4) RNA enhances the maturation of DC. Immature DC were cotransfected…”
    Get full text
    Journal Article
  10. 10

    In-transit melanoma: The role of alkylating-agent resistance in regional therapy by Grubbs, Elizabeth G., Abdel-Wahab, Omar, Cheng, Tsung-Yen, Abdel-Wahab, Zeinab, Peterson, Bercedis, Pruitt, Scott K., Colvin, O.Michael, Friedman, Henry S., Tyler, Douglas S.

    “…Regional perfusion treatments for melanoma, using the alkylating agent melphalan, show variable responses in magnitude and duration. Surprisingly, the…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity by Kalady, Matthew F, Onaitis, Mark W, Emani, Sirisha, Abdel-Wahab, Zeinab, Tyler, Douglas S, Pruitt, Scott K

    Published in The Journal of surgical research (2004)
    “…Despite the increasing use of dendritic cells (DCs) in clinical trials, questions regarding the optimal means of DC preparation, in particular how to achieve…”
    Get full text
    Journal Article
  12. 12
  13. 13

    CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy by Onaitis, Mark W., Kalady, Matthew F., Emani, Sirisha, Abdel-Wahab, Zeinab, Tyler, Douglas S., Pruitt, Scott K.

    Published in Surgery (01-08-2003)
    “…Background. Dendritic cell (DC)-based immunotherapy is a promising form of adjuvant therapy for high-risk tumors. DCs transfected with tumor-associated…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Vaccination with Dendritic Cells Inhibits the Growth of Hepatic Metastases in B6 Mice by DeMatos, Pierre, Abdel-Wahab, Zeinab, Vervaert, Carol, Seigler, Hilliard F.

    Published in Cellular immunology (10-04-1998)
    “…Dendritic cells (DC) are specialized antigen-presenting cells that can activate naive and mature T-cells, induce cellular immunity, and stimulate strong…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Human Dendritic Cells, Pulsed with either Melanoma Tumor Cell Lysates or the gp100 Peptide(280-288), Induce Pairs of T-Cell Cultures with Similar Phenotype and Lytic Activity by Abdel-Wahab, Zeinab, DeMatos, Pierre, Hester, Dina, Dong, Xiang Da, Seigler, Hilliard F.

    Published in Cellular immunology (25-05-1998)
    “…Dendritic cells (DCs) pulsed with unfractionated tumor cell lysates or defined tumor peptides provide potent vaccines which elicit strong antitumor immunity…”
    Get full text
    Journal Article
  17. 17

    Generation of Melanoma-Specific, Cytotoxic CD4+ T Helper 2 Cells: Requirement of both HLA-DR15 and Fas Antigens on Melanomas for Their Lysis by Th2 Cells by Zennadi, Rahima, Abdel-Wahab, Zeinab, Seigler, Hilliard F., Darrow, Timothy L.

    Published in Cellular immunology (15-06-2001)
    “…Recognition of melanoma antigens by HLA class-II-restricted CD4+ T lymphocytes has been investigated. Two cytotoxic CD4+ T cell lines were established by…”
    Get full text
    Journal Article
  18. 18

    Effect of Irradiation on Cytokine Production, MHC Antigen Expression, and Vaccine Potential of Interleukin-2 and Interferon-γ Gene-Modified Melanoma Cells by Abdel-Wahab, Zeinab, Dar, Mohammed M., Hester, Dina, Vervaert, Carol, Gangavalli, Ramarao, Barber, Jack, Darrow, Timothy L., Seigler, Hilliard F.

    Published in Cellular immunology (01-08-1996)
    “…Recent studies have shown that tumor cells transduced with interleukin-2 (IL-2) or interferon-γ (IFN-γ) genes stimulated a potent and specific antitumor…”
    Get full text
    Journal Article
  19. 19

    A phase I clinical trial of immunotherapy with interferon‐γ gene‐modified autologous melanoma cells by AbdelWahab, Zeinab, Weltz, Christina, Hester, Dina, Pickett, Nancy, Vervaert, Carol, Barber, Jack R., Jolly, Douglas, Seigler, Hilliard F.

    Published in Cancer (01-08-1997)
    “…BACKGROUND Tumor cells transduced with cytokine genes provide immunogenic vaccines for cancer immunotherapy. METHODS A Phase I clinical trial was conducted for…”
    Get full text
    Journal Article
  20. 20